News from the FDA/CDC

New at-home test approved for chlamydia and gonorrhea


 

People who want to be tested for chlamydia and gonorrhea are now able to do so without leaving their homes.

Called Simple 2, it’s the first test approved by the Food and Drug Administration that uses a sample collected at home to test for an STD, other than tests for HIV. The test can be purchased over-the-counter in stores or ordered online and delivered in discreet packaging. A vaginal swab or urine sample is collected and then sent for laboratory testing using a prepaid shipping label.

The FDA issued the final needed approval on Nov. 15, and the product is already for sale on the website of the manufacturer, LetsGetChecked. The listed price is $99 with free shipping for a single test kit, and the site offers a discounted subscription to receive a kit every 3 months for $69.30 per kit.

Gonorrhea cases have surged 28% since 2017, reaching 700,000 cases during 2021, Centers for Disease Control and Prevention data show. Chlamydia has also been on the rise, up 4% from 2020 to 2021, with 1.6 million annual infections.

Previously, tests for the two STDs required that samples be taken at a health care location such as a doctor’s office. The Simple 2 test results can be retrieved online, and a health care provider will reach out to people whose tests are positive or invalid. Results are typically received in 2-5 days, according to a press release from LetsGetChecked, which also offers treatment services.

“This authorization marks an important public health milestone, giving patients more information about their health from the privacy of their own home,” said Jeff Shuren, MD, JD, director of the FDA’s Center for Devices and Radiological Health, in a statement. “We are eager to continue supporting greater consumer access to diagnostic tests, which helps further our goal of bringing more health care into the home.”

A version of this article first appeared on WebMD.com.

Recommended Reading

Tech encourages HIV prevention among women
MDedge Family Medicine
People with long COVID don’t show signs of brain damage
MDedge Family Medicine
Test all perinatally exposed infants for HCV: CDC
MDedge Family Medicine
Laissez-faire
MDedge Family Medicine
Keep COVID-19 vaccination on your patients’ radar
MDedge Family Medicine
No longer a death sentence, HIV diagnosis still hits hard
MDedge Family Medicine
The remaining frontiers in fighting hepatitis C
MDedge Family Medicine
CDC says child vaccination exemptions hit all-time high
MDedge Family Medicine
AI tool perfect in study of inflammatory diseases
MDedge Family Medicine
Saltwater gargling may help avoid COVID hospitalization
MDedge Family Medicine